MeTA - Zambia

Zambia is one of the seven countries taking part in the pilot phase of MeTA. The resources listed below relate specifically to Zambia.

We will add to this key list over time and would welcome suggestions or additions. Please send these to: sourceassistant@hi-uk.org

Selected resources

Books, reports, etc

Pain relieving drugs in 12 African PEPFAR countries : mapping current providers, identifying current challenges, and enabling expansion of pain control provision in the management of HIV/AIDS

HARDING, Richard
et al
January 2007

Expand view

This study aims to identify current opioid prescribing services and regulatory bodies within 12 African PEPFAR (Presidents Emergency Plan for AIDS Relief ) countries, and to examine the barriers to, and appraise the potential for, expansion in the number of opioid providers, for people with HIV and AIDS according to the World Health Organization pain ladder. It concludes that while there are common issues raised by services and International Narcotics Control Board competent authorities, it is clear that these key stakeholders have concerns regarding the potential roll-out of opioids

Understanding the private sector anti-malarial market in Zambia

CLINTON FOUNDATION
June 2008

Expand view

These are the findings of a rapid analysis of private retail and wholesale outlets in six districts of Zambia to guide ongoing deliberations on a national private sector artemisinin-based combination therapies (ACTs) subsidy. Despite being one of the first countries to adopt ACTs, access to these treatments in Zambia has remained low, reaching only eight per cent of children under five within 24 hours in 2006. The accompanying file contains maps of the six districts - Choma, Kabwe, Kafue, Lundazi, Mwense and Samfya

Serials

Safe medicines project - phase II : the Zambian case study

AFRICA FIGHTING MALARIA
March 2009

Expand view

This bulletin reports on the results of a study in which a range of antimalarial drugs were procured from private pharmacies, shops and kiosks within the urban and peri-urban areas of Lusaka, Zambia and tested to measure the active pharmaceutical ingredient content against internationally acceptable standards

Journal articles

Action from the grassroots to parliament : access to essential medicines gets an airing in Zambia

CHOTA, Lazarus
et al
January 2010

Expand view

The unique position of stakeholders participating in the Medicines Transparency Alliance Zambia, means that the group are able to initiate discussions at many levels from grassroots to parliament. This is of great value in highlighting critical issues about the lack of access to essential medicines experienced by many citizens in Zambia and makes progress towards finding some solutions

Antimalarial drug quality in the most severely malarious parts of Africa - a six country study

BATE, Roger
et al
May 2008

Expand view

This article describes research conducted on a range of antimalarial drugs, procured from private pharmacies in urban and peri-urban areas in the major cities of six African countries which were subjected to semi-quantitative thin-layer chromatography (TLC) and dissolution testing to measure active pharmaceutical ingredient content against internationally acceptable standards